Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1422 of 6351
-
New adaptive radiation trial aims to cut prostate cancer treatment time without sacrificing quality of life
Disease control Recruiting nowIn this prospective, multi-center cohort study, the tolerability and quality of life during ultrahypofractionated radiotherapy (RT) of early stage prostate cancer is surveyed at several institutions in Germany. Radiotherapy is delivered by an online-adaptive RT device (Varian Eth…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
AI heart scans could replace MRI for chemo patients
Diagnosis Not yet recruitingTo investigate the clinical utility of both 3D and 2D artificial intelligence reconstruction echocardiography (V-echo and L-echo) assessment against conventional echocardiography and clinical cardiovascular magnetic resonance (CMR) imaging for the characterisation of cardiac func…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New hope for rare joint disease: arthritis drug tocilizumab tested in CPPD
Disease control Not yet recruitingThe aim of this clinical trial is to determine the efficacy of tocilizumab (an IL-6 inhibitor) in treatment-refractory chronic inflammatory forms of CPPD. The main questions this trial aims to answer are: * Can tocilizumab improve joint pain in patients with chronic inflammator…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Cannabis oil trial aims to ease cancer Patients' daily suffering
Symptom relief Not yet recruitingCAPTURE is a prospective, interventional, randomized, phase 2, double-blind, placebo-controlled study assessing the therapeutic add-on effect of the balanced THC/CBD extract (Cannabis extract Avextra 10/10 oral solution) on symptom burden in patients with advanced oncological dis…
Phase 2 • Sponsor: National Cancer Institute, Naples • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
One-Patient trial aims to treat Ultra-Rare genetic disorder
Disease control Not yet recruitingThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug intended for a single participant with Schuurs-Hoeijmakers syndrome (SHMS) due to a pathogenic, de novo, heterozygous missense gain-of-function mutation in PACS1
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Pre-Surgery workouts may boost recovery in lung cancer
Symptom relief Not yet recruitingThe PREHAB study focuses on patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemotherapy and/or immunotherapy prior to surgical resection. These systemic treatments frequently impair patients' physiological reserve, reduce physical fitness…
Sponsor: Hôpital du Valais • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New gout pill BR2251 enters Mid-Stage trial
Disease control Not yet recruitingThis study is a randomized, double-blind, non-befloxacin-controlled, multicenter, phase II clinical trial, evaluating the efficacy, safety, and pharmacokinetic characteristics of BR2251 tablets when administered multiple times in subjects with primary gout and hyperuricemia. Thi…
Phase 2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Extra radiation boost may help control spine tumors and ease pain
Disease control Recruiting nowSpine SBRT is considered a standard of care for the treatment of spinal metastases. Compared to conventional radiation therapy, spine SBRT delivers high doses of radiation to the affected areas to the spinal metastases. This study is interested in seeing whether an additional 'b…
Phase 2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a stronger blood thinner save trauma patients from deadly clots?
Prevention Not yet recruitingVenous thromboembolism is a frequent issue in severe trauma patients. Guidelines for venous thromboembolism prevention include the use of pharmacological thromboprophylaxis, mainly with low-molecular-weight heparin, and/or mechanical thromboprophylaxis. However, a high incidence …
Sponsor: University Hospital, Grenoble • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Can a fungus slow ALS? new trial targets high sphingolipids
Disease control Not yet recruitingAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the degeneration of motor neurons, leading to progressive muscle weakness and functional decline. This study is designed as a randomized, double-blind, placebo-controlled clinical tria…
Phase 2 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New study tests extra treatments for kids whose nearsightedness keeps getting worse despite special lenses
Disease control Not yet recruitingMyopia has emerged as a significant concern impacting the visual health of children and adolescents on a global scale. According to research conducted by Holden BA et al., it is projected that by the year 2050, the worldwide prevalence of myopia and high myopia will experience a …
Sponsor: Tianjin Medical University Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
AI and 3D imaging join forces to spot breast cancer faster
Diagnosis Not yet recruitingBreast cancer remains the most commonly diagnosed cancer and a leading cause of cancer-related mortality among women globally. Timely and accurate detection is crucial for improving prognosis and survival outcomes. While digital mammography has long served as the gold standard fo…
Sponsor: Jean Seely • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could a 5-Day diet boost kidney cancer treatment?
Disease control Not yet recruitingThis study is testing whether adding a 5-day fasting-mimicking diet (FMD) can help people with advanced kidney cancer when given together with standard first-line cancer medicines.
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Acupuncture tackles Post-Stroke swallowing woes in massive new trial
Disease control Recruiting nowEmploying a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different int…
Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New surgery aims to remove stomach tumors without major incisions
Disease control By invitation onlyThis study is a single-center, prospective, single-arm, exploratory clinical study (phase II exploratory trial). No parallel control group was established in the study, and all subjects who met the inclusion criteria underwent a uniform surgical treatment approach, namely, double…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Blood test could predict chronic GVHD after transplant
Knowledge-focused Not yet recruitingThis study is a single-center observational clinical study. Participants were enrolled as two cohorts of patients including discovery cohort and validation cohort. A total of consecutive 1000 patients receiving allo-HSCT in our center from 2021.01 to 2023.06 were retrospectively …
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can a simple saltwater drip improve stroke outcomes? new trial aims to find out.
Disease control Not yet recruitingThe intravenous administration of abundant normal saline is an easy-to-use strategy commonly employed to expand the blood volume. This study aimed to evaluate the efficacy and safety of the early administration of an abundant normal saline infusion after intravenous thrombolysis …
Phase 3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart failure hope? major trial tests Selenium's power
Disease control Recruiting nowHeart failure is a serious condition in which the heart is unable to pump blood effectively, and it remains a leading cause of hospitalization and death worldwide despite advances in treatment. Selenium is an essential micronutrient that plays an important role in cellular energ…
Phase 3 • Sponsor: Skane University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug trial hopes to shrink Hard-to-Treat pancreatic tumors
Disease control Not yet recruitingThis is a multicenter, prospective, open-label Phase II clinical study designed to evaluate the efficacy and safety of sacituzumab govitecan monotherapy in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma who have failed at least one prior line of the…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI reads emotions to predict bipolar episodes
Knowledge-focused Recruiting nowBipolar disorder (BD) has become a significant public health problem with complex clinical manifestations, difficult treatment, and poor prognosis. However, there is still a lack of effective biological markers for diagnosing and predicting recurrence. Sentiment analysis computin…
Sponsor: Shanghai Mental Health Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC